1. Home
  2. NXN vs RFL Comparison

NXN vs RFL Comparison

Compare NXN & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXN
  • RFL
  • Stock Information
  • Founded
  • NXN 1992
  • RFL 2017
  • Country
  • NXN United States
  • RFL United States
  • Employees
  • NXN N/A
  • RFL N/A
  • Industry
  • NXN Trusts Except Educational Religious and Charitable
  • RFL Real Estate
  • Sector
  • NXN Finance
  • RFL Finance
  • Exchange
  • NXN Nasdaq
  • RFL Nasdaq
  • Market Cap
  • NXN 46.8M
  • RFL 55.3M
  • IPO Year
  • NXN N/A
  • RFL N/A
  • Fundamental
  • Price
  • NXN $11.45
  • RFL $1.92
  • Analyst Decision
  • NXN
  • RFL
  • Analyst Count
  • NXN 0
  • RFL 0
  • Target Price
  • NXN N/A
  • RFL N/A
  • AVG Volume (30 Days)
  • NXN 9.7K
  • RFL 27.8K
  • Earning Date
  • NXN 01-01-0001
  • RFL 12-27-2024
  • Dividend Yield
  • NXN 4.23%
  • RFL N/A
  • EPS Growth
  • NXN N/A
  • RFL N/A
  • EPS
  • NXN 0.24
  • RFL N/A
  • Revenue
  • NXN N/A
  • RFL $697,000.00
  • Revenue This Year
  • NXN N/A
  • RFL N/A
  • Revenue Next Year
  • NXN N/A
  • RFL N/A
  • P/E Ratio
  • NXN $48.42
  • RFL N/A
  • Revenue Growth
  • NXN N/A
  • RFL 151.62
  • 52 Week Low
  • NXN $10.64
  • RFL $1.29
  • 52 Week High
  • NXN $12.45
  • RFL $2.50
  • Technical
  • Relative Strength Index (RSI)
  • NXN 22.27
  • RFL 53.58
  • Support Level
  • NXN $11.63
  • RFL $1.71
  • Resistance Level
  • NXN $11.69
  • RFL $1.92
  • Average True Range (ATR)
  • NXN 0.12
  • RFL 0.10
  • MACD
  • NXN -0.04
  • RFL -0.00
  • Stochastic Oscillator
  • NXN 0.00
  • RFL 84.00

About NXN Nuveen New York Select Tax-Free Income Portfolio

Nuveen NY Select Tax-Free Income Port is a diversified closed-end management investment company. Its investment objective are to provide current income exempt from regular federal and New Jersey income tax, and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

Share on Social Networks: